Clinical Topics & News
News
Pediatric, adolescent migraine treatment and prevention guidelines are updated
The guidelines review both pharmacologic and nonpharmacologic options, which have multiplied since the previous guidelines were released in 2004...
Clinical Topics & News
Gepant Safety & Lack of Liver Toxicity: Highlights from AAN 2019
Clinical Topics & News
Marcela Romero-Reyes, DDS, PhD, Comments on Peripheral and Central Headache Challenges
Clinical Topics & News
Experts Weigh in on Medication Overuse Headache
Clinical Topics & News
Behavioral Therapy for Migraine and Tension-Type Headache
Clinical Topics & News
Physician Commentary: Neurology Community Responds to Diclofenac Cardiovascular Risks
Article
FDA Approves Galcanezumab for Migraine Prevention
ROCKVILLE, MD—The FDA has approved galcanezumab-gnlm (Emgality) for the preventive treatment of migraine in adults. Eli...
Clinical Topics & News
Alan M. Rapoport, MD, on Medication Overuse Headache
Article
Teva Announces FDA Approval of Ajovy (fremanezumab-vfrm)
Teva Pharmaceutical Industries Ltd. announced that the FDA approved Ajovy (fremanezumab-vfrm) injection for the preventive treatment of migraine...